Abstract | BACKGROUND: METHOD: We describe an exhibitionist treated under partial single-blind conditions (patient was blind to placebo but was aware he was receiving desipramine and fluvoxamine) with the serotonin selective reuptake inhibitor fluvoxamine, followed by desipramine and a placebo that looked like fluvoxamine, in an ABACA design. He was serially assessed with the Yale-Brown Obsessive Compulsive Scale. RESULTS:
Fluvoxamine eliminated the undesired impulse and behavior without affecting sexual desire. Desipramine and single-blind fluvoxamine-placebo treatment were both associated with relapses. CONCLUSION: A subset of paraphiliacs may be suffering from obsessive-compulsive-related disorders and may benefit from serotonergic agents.
|
Authors | J Zohar, Z Kaplan, J Benjamin |
Journal | The Journal of clinical psychiatry
(J Clin Psychiatry)
Vol. 55
Issue 3
Pg. 86-8
(Mar 1994)
ISSN: 0160-6689 [Print] United States |
PMID | 8071253
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Placebos
- Fluvoxamine
- Desipramine
|
Topics |
- Adult
- Desipramine
(therapeutic use)
- Exhibitionism
(complications, drug therapy, psychology)
- Fluvoxamine
(therapeutic use)
- Humans
- Male
- Masturbation
(complications, drug therapy, psychology)
- Obsessive-Compulsive Disorder
(complications, drug therapy, psychology)
- Placebos
- Psychiatric Status Rating Scales
- Single-Blind Method
- Treatment Outcome
|